We are a 501(c)3 non-profit with a mission to help deliver on the promise of regenerative medicine by conducting research to de-risk technologies, promoting progress of biomanufacturing scale-up and automation to make technologies more affordable, and speeding up the translation to clinical practice.
Advanced Biomanufacturing Initiatives developing platform technologies to address industry’s most pressing manufacturing needs. Projects include universal bioink, universal cell media and bioreactors.
RegeneratOR, a first of its kind in regenerative medicine, invisioned with three parts: a test bed for new technologies, business incubator for start ups, and workforce development to train highly skilled biomanufacturing technicians and researchers.
Society and consortia provide opportunities for making therapies to patients a reality.
What we will achieve:
Future organoid technology and applications to biopharma
Advanced training programs that will develop a highly-skilled workforce from lab and biomanufacturing technicians to graduate students and post-doctorate fellows
Help regenerative medicine start-ups and growth companies through the business incubator with operational support, market potential validation, management, benefit analysis, financial planning, budgeting, and more
Integration of advanced regenerative medicine technologies into translational GMP facilities that will pave the way for wide-spread integration and adoption of regenerative medicine manufacturing processes